Cross Country Healthcare, Inc. (CCRN)
NASDAQ: CCRN · Real-Time Price · USD
10.06
-0.16 (-1.52%)
Nov 21, 2024, 12:09 PM EST - Market open
Cross Country Healthcare Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for CCRN stock have an average target of 18.5, with a low estimate of 15 and a high estimate of 22. The average target predicts an increase of 83.99% from the current stock price of 10.06.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CCRN stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 1 | 1 | 1 | 1 |
| Hold | 5 | 5 | 4 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Strong Buy Maintains $19 → $18 | Strong Buy | Maintains | $19 → $18 | +79.02% | Nov 7, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $17 → $15 | Hold | Maintains | $17 → $15 | +49.18% | Oct 21, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $21 → $19 | Buy | Maintains | $21 → $19 | +88.96% | Aug 8, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $16 → $17 | Hold | Maintains | $16 → $17 | +69.07% | Aug 1, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $24 → $21 | Buy | Maintains | $24 → $21 | +108.85% | May 6, 2024 |
Financial Forecast
Revenue This Year
1.37B
from 2.02B
Decreased by -32.02%
Revenue Next Year
1.30B
from 1.37B
Decreased by -5.32%
EPS This Year
0.53
from 2.05
Decreased by -74.19%
EPS Next Year
0.60
from 0.53
Increased by 13.49%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 1.4B | 1.4B | 1.4B |
| Avg | 1.4B | 1.3B | 1.3B |
| Low | 1.3B | 1.2B | 1.2B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -29.5% | 3.4% | 8.2% |
| Avg | -32.0% | -5.3% | 2.2% |
| Low | -35.0% | -14.2% | -4.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.57 | 0.83 | 0.80 |
| Avg | 0.53 | 0.60 | 0.71 |
| Low | 0.47 | 0.37 | 0.64 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -72.3% | 56.8% | 32.9% |
| Avg | -74.2% | 13.5% | 17.6% |
| Low | -77.1% | -29.6% | 6.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.